Two Sigma Advisers’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.52M | Buy |
700,900
+167,900
| +32% | +$604K | 0.01% | 1011 |
|
|
2025
Q1 | $1.59M | Buy |
533,000
+39,400
| +8% | +$118K | ﹤0.01% | 1251 |
|
|
2024
Q4 | $1.65M | Sell |
493,600
-88,800
| -15% | -$297K | ﹤0.01% | 1214 |
|
|
2024
Q3 | $1.95M | Sell |
582,400
-29,800
| -5% | -$99.8K | ﹤0.01% | 1077 |
|
|
2024
Q2 | $2.03M | Buy |
612,200
+34,800
| +6% | +$115K | ﹤0.01% | 1187 |
|
|
2024
Q1 | $2.33M | Buy |
577,400
+258,300
| +81% | +$1.04M | 0.01% | 1137 |
|
|
2023
Q4 | $973K | Buy |
319,100
+113,200
| +55% | +$345K | ﹤0.01% | 1662 |
|
|
2023
Q3 | $618K | Buy |
205,900
+159,300
| +342% | +$478K | ﹤0.01% | 1713 |
|
|
2023
Q2 | $174K | Buy |
+46,600
| New | +$174K | ﹤0.01% | 2123 |
|
|
2022
Q3 | – | Sell |
-21,800
| Closed | -$155K | – | 2541 |
|
|
2022
Q2 | $155K | Sell |
21,800
-75,500
| -78% | -$537K | ﹤0.01% | 2325 |
|
|
2022
Q1 | $703K | Buy |
97,300
+41,100
| +73% | +$297K | ﹤0.01% | 1817 |
|
|
2021
Q4 | $502K | Buy |
+56,200
| New | +$502K | ﹤0.01% | 1909 |
|
|
2021
Q3 | – | Sell |
-13,900
| Closed | -$299K | – | 2443 |
|
|
2021
Q2 | $299K | Buy |
+13,900
| New | +$299K | ﹤0.01% | 2141 |
|